Can a simple heart pump save lives after a heart attack complication?

NCT ID NCT07267884

Not yet recruiting Disease control Sponsor: Qilu Hospital of Shandong University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether inserting a heart pump (IABP) early, before severe shock develops, can reduce deaths in patients who develop a hole in the heart after a heart attack. The trial will enroll 100 patients across 5 centers, randomly assigning half to receive the pump within 8 hours plus standard care, and half to standard care alone. The main goal is to see if early pump use lowers the chance of dying within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intra-aortic balloon pump (IABP) - a device inserted into the main artery to help the heart pump blood
What this could lead to: If successful, this could show that early IABP use reduces deaths in patients with a hole in the heart after a heart attack, offering a bridge to surgery.
What could go wrong: This is a small, early-stage trial (100 patients) and previous larger studies found IABP did not improve survival in similar conditions. The device also carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction Shock, Cardiogenic ventricular septal defect

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION (AMI) VENTRICULAR SEPTAL DEFECTS (VSD)

Contacts and locations

Locations

Department of Cardiology, Qilu Hospital of Shandong University

Jinan, Shandong, 250012, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.